Solo Practices Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice (ACT-SOLO)
Condition:   Rheumatoid ArthritisIntervention:   Sponsor:   Hoffmann-La RocheCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2011 Category: Research Source Type: clinical trials

An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice (ACT-SOLO)
Condition:   Rheumatoid ArthritisIntervention:   Sponsor:   Hoffmann-La RocheCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2011 Category: Research Source Type: clinical trials

An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice (ACT-SOLO)
Condition:   Rheumatoid ArthritisIntervention:   Sponsor:   Hoffmann-La RocheCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2011 Category: Research Source Type: clinical trials

An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice (ACT-SOLO)
Condition:   Rheumatoid ArthritisIntervention:   Sponsor:   Hoffmann-La RocheCompleted - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2011 Category: Research Source Type: clinical trials